Hepatocellular carcinoma in a 12-year-old child with piZZ α1-antitrypsin deficiency [1]

Hepatology

Volumn 43, Issue 1, 2006, Pages 194-

  Hadzic, Nedim ^a   Quaglia, Alberto ^a   Mieli Vergani, Giorgina ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN;

ALPHA 1 ANTITRYPSIN DEFICIENCY; ANAMNESIS; CARCINOGENESIS; CASE REPORT; CLINICAL EXAMINATION; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; HUMAN; LABORATORY TEST; LETTER; LIVER CELL CARCINOMA; LIVER DISEASE; LIVER RESECTION; LIVER TRANSPLANTATION; PRIORITY JOURNAL; SCHOOL CHILD; CHILD; LIVER TUMOR; NOTE; PATHOLOGY;

ALPHA 1-ANTITRYPSIN DEFICIENCY; CARCINOMA, HEPATOCELLULAR; CHILD; FEMALE; HUMANS; LIVER NEOPLASMS;

EID: 33644809500     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.21009     Document Type: Letter

References (5)

1. Rudnik DA, Perlmutter DH. Alpha-1-antitrypsin deficiency: a new paradigm for hepatocellular carcinoma in genetic liver disease. HEPATOLOGY 2005;42:514-521.
2. Geller SA, Nichols WS, Kim S, Tolmachoff T, Lee S, Dycaico MJ, et al. Hepatocarcinogenesis is the sequel to hepatitis in Z#2 α1-antitrypsin transgenic mice: histopathological and DNA ploidy studies. HEPATOLOGY 1994;19:389-397.
3. Talbot IC, Mowat AP. Liver disease in infancy: histological features and relationship to α1-antitrypsin phenotype. J Clin Pathol 1975;28:559-563.
4. Vennarecci G, Gunson BK, Ismail T, Hubscher SG, Kelly DA, McMaster P, et al. Transplantation for end stage liver disease related to alpha 1 antitrypsin. Transplantation 1996;61:1488-1495.
5. Hadzic N, Francavilla R, Chambers SM, Castellaneta S, Portmann B, Mieli-Vergani G. Outcome of PiSS and PiSZ alpha-1-antitrypsin deficiency presenting with liver involvement. Eur J Pediatr 2005;164:250-252.